FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Maziarz

Research Profile

Procedures

Concepts & Ideas

Disorders

Phenomena

Recurrence

Living Beings

Young Adult

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Angela G Fleischman; Richard T Maziarz
Hematopoietic stem cell transplantation for myelofibrosis: where are we now?
Leena V Maramattom; David I Marks; Richard T Maziarz; Silvia Montoto; David A Rizzieri; Baldeep Wirk; William Arcese; Linda J Burns; Mitchell S Cairo; Jeanette Carreras; Luciano J Costa; Timothy S Fenske; Cesar O Freytes; Robert Peter Gale; Thomas G Gross; gregory alan hale; Mehdi Hamadani; Parameswaran Hari; Leona A Holmberg; Jack W Hsu; David J Inwards; Hillard M Lazarus; Michael Lill; David G Maloney; James L Gajewski
Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.
Karen Ballen; Vicki Boussiotis; Corey Cutler; Colleen Delaney; Bimalangshu R Dey; Vincent T Ho; Katarzyna Jamieson; Ram Kamble; John Koreth; Richard T Maziarz; Steven McAfee; Philip McCarthy; Adam M Mendizabal; Ioannis Politikos; Elizabeth J Shpall; Robert Soiffer; Thomas R Spitzer; John R Wingard; Edwin Alyea; Eyal C Attar; David Avigan; Edward D Ball; Joseph H Antin
Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Maziarz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Angela G Fleischman; Richard T Maziarz
Hematopoietic stem cell transplantation for myelofibrosis: where are we now?
Current opinion in hematology 2013;20(2):130-6.
2013: Leena V Maramattom; David I Marks; Richard T Maziarz; Silvia Montoto; David A Rizzieri; Baldeep Wirk; William Arcese; Linda J Burns; Mitchell S Cairo; Jeanette Carreras; Luciano J Costa; Timothy S Fenske; Cesar O Freytes; Robert Peter Gale; Thomas G Gross; gregory alan hale; Mehdi Hamadani; Parameswaran Hari; Leona A Holmberg; Jack W Hsu; David J Inwards; Hillard M Lazarus; Michael Lill; David G Maloney; James L Gajewski
Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):173-9.
2012: Karen Ballen; Vicki Boussiotis; Corey Cutler; Colleen Delaney; Bimalangshu R Dey; Vincent T Ho; Katarzyna Jamieson; Ram Kamble; John Koreth; Richard T Maziarz; Steven McAfee; Philip McCarthy; Adam M Mendizabal; Ioannis Politikos; Elizabeth J Shpall; Robert Soiffer; Thomas R Spitzer; John R Wingard; Edwin Alyea; Eyal C Attar; David Avigan; Edward D Ball; Joseph H Antin
Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(12):1851-8.
2012: Andy I Chen; C Fowler; R Knight; T Bains; Joseph S Bubalo; S Murray; K Shoop; S Slater; Richard T Maziarz
Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization.
Bone marrow transplantation 2012;47(12):1526-9.
2012: Ulrike Bacher; Michael R Bishop; Christopher N Bredeson; Mitchell S Cairo; Jeanette Carreras; Timothy S Fenske; Cesar O Freytes; Robert Peter Gale; John Gibson; Parameswaran Hari; David J Inwards; Luis M Isola; Evgeny Klyuchnikov; Ginna G Laport; Hillard M Lazarus; Jennifer Le-Rademacher; Richard T Maziarz; Harry C Schouten; Shimon Slavin; Sonali M Smith; Julie M Vose; Edmund K Waller; Peter H Wiernik; Philippe Armand
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Blood 2012;120(20):4256-62.
2012: Auayporn P Nademanee; Edward A Stadtmauer; Patrick J Stiff; Gary Bridger; John F DiPersio; Frank J Hsu; Richard T Maziarz; Ivana N Micallef; Brian J Bolwell
Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(10):1564-72.
2012: Karen K Ballen; Brian Bolwell; Jean Yves Cahn; Matthew H Carabasi; Ed Copelan; Jorge Cortes; H Joachim Deeg; Biju George; Vikas Gupta; Gregory Hale; Joerg Halter; Mehdi Hamadani; Mary M Horowitz; Matt E Kalaycio; Ian Lewis; Richard T Maziarz; Philip McCarthy; Steven Pavletic; David L Porter; Kwang Woo Ahn; Mahmoud Aljurf; Joseph Antin; Mukta Arora; Bipin N Savani; Harry C Schouten; Baldeep Wirk; Ann E Woolfrey; Xiaochun Zhu; Wael Saber
Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1446-54.
2012: H J Khoury; M Kukreja; D I Marks; Richard T Maziarz; P L McCarthy; D A Rizzieri; Jeff Szer; T Wang; A Woolfrey; M Arora; J Cortes; Robert Peter Gale; B George; S A Giralt; J M Goldman; V Gupta; J Halter; M M Horowitz; A Keating; S J Lee
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.
Bone marrow transplantation 2012;47(6):810-6.
2012: Jeffery J Auletta; Amelia Bartholomew; Robert J Deans; Hillard M Lazarus; Richard T Maziarz; Robert H Miller; Jeffrey A Cohen
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.
Immunotherapy 2012;4(5):529-47.
2011: Liz Cooke; Deborah H Eldredge; Marcia Grant; Richard T Maziarz; Lillian M Nail
Informal caregiving in Hematopoietic Blood and Marrow Transplant patients.
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2011;15(5):500-7.
2011: Mohamed L Sorror; Barry E Storer; Lars Vindeløv; Andrew Yeager; Edward Agura; Wolfgang Bethge; Karl G Blume; Benedetto Bruno; Thomas R Chauncey; Georg N Franke; George E Georges; Parameswaran Hari; Kai Hübel; Amelia Langston; Ginna G Laport; David G Maloney; Michael B Maris; Richard T Maziarz; Peter A McSweeney; Marco Mielcarek; Dietger Niederwieser; Finn Bo Petersen; Michael Allen Pulsipher; Firoozeh Sahebi; Brenda M Sandmaier; Rainer Storb
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA : the journal of the American Medical Association 2011;306(17):1874-83.
2011: Richard T Maziarz; Dawn Driscoll
Hematopoietic stem cell transplantation and implications for cell therapy reimbursement.
Cell stem cell 2011;8(6):609-12.
2011: Luis Espinosa-Aguilar; Jaime S Green; Graeme N Forrest; Edward D Ball; Richard T Maziarz; Lynne Strasfeld; Randy A Taplitz
Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(4):566-73.
2011: Alison W Loren; Eric Chow; David A Jacobsohn; Maria Gilleece; Joerg Halter; Sarita Joshi; Zhiwei Wang; Kathleen A Sobocinski; Vikas Gupta; gregory alan hale; David I Marks; Edward A Stadtmauer; Jane Apperley; Jean-Yves Cahn; Harry C Schouten; Hillard M Lazarus; Bipin N Savani; Philip L McCarthy; Ann A Jakubowski; Naynesh R Kamani; Brandon Hayes-Lattin; Richard T Maziarz; Anne B Warwick; Mohamed L Sorror; Brian J Bolwell; Gerard Socié; John R Wingard; J Douglas Rizzo; Navneet S Majhail
Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(2):157-66.
2011: Paul J Martin; Barry E Storer; Paul A Carpenter; Daniel Couriel; Mary E D Flowers; Vikas Gupta; Jack W Hsu; Madan Jagasia; Carrie L Kitko; Richard T Maziarz; Scott D Rowley; Paul J Shaughnessy; Koen van Besien; Daniel Weisdorf; Stephanie J Lee
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(1):124-32.
2010: Robert Deans; Kurt C Gunter; Timothy Allsopp; Mark Bonyhadi; Scott R Burger; Melissa Carpenter; Tara Clark; Charles S Cox; Dawn Driscoll; Ed Field; Ralf Huss; René Lardenoije; Tracey A Lodie; Chris Mason; Richard Neubiser; John E J Rasko; Jon Rowley; Richard T Maziarz
A changing time: the International Society for Cellular Therapy embraces its industry members.
Cytotherapy 2010;12(7):853-6.
2010: Gabrielle Meyers; Richard T Maziarz
Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.
Bone marrow transplantation 2010;45(10):1479-88.
2010: Jorge Cortes; Joseph O Moore; Richard T Maziarz; Meir Wetzler; Michael Craig; Jeffrey Matous; Selina Luger; Bimalangshu R Dey; Gary J Schiller; Dat Pham; Camille N Abboud; Muthuswamy Krishnamurthy; Archie Brown; Abderrahmane Laadem; Karen Seiter
Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4207-13.
2010: Michel Duval; John P Klein; Wensheng He; Jean-Yves Cahn; Mitchell S Cairo; Bruce M Camitta; Rammurti Kamble; Edward A Copelan; Marcos de Lima; Vikas Gupta; Armand Keating; Hillard M Lazarus; Mark R Litzow; David I Marks; Richard T Maziarz; David A Rizzieri; Gary Schiller; Kirk R Schultz; Martin S Tallman; Daniel Weisdorf
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(23):3730-8.
2010: Jeffrey Schriber; Manza-A Agovi; Vincent Ho; Karen K Ballen; Andrea Bacigalupo; Hillard M Lazarus; Christopher N Bredeson; Vikas Gupta; Richard T Maziarz; gregory alan hale; Mark R Litzow; Brent Logan; Martin Bornhauser; Roger H Giller; Luis Isola; David I Marks; J Douglas Rizzo; Marcelo C Pasquini
Second unrelated donor hematopoietic cell transplantation for primary graft failure.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(8):1099-106.
2010: Boglarka Gyurkocza; Rainer Storb; Barry E Storer; Thomas R Chauncey; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Christopher N Bredeson; Richard T Maziarz; Benedetto Bruno; Finn B Petersen; Michael B Maris; Edward Agura; Andrew Yeager; Wolfgang A Bethge; Firoozeh Sahebi; Frederick R Appelbaum; David G Maloney; Brenda M Sandmaier
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2859-67.
2010: Brian L McClune; Daniel J Weisdorf; Tanya L Pedersen; Gisela Tunes da Silva; Martin S Tallman; Jorge Sierra; John DiPersio; Armand Keating; Robert P Gale; Biju George; Vikas Gupta; Theresa Hahn; Luis Isola; Madan Jagasia; Hillard Lazarus; David Marks; Richard T Maziarz; Edmond WALLER; Chris Bredeson; Sergio Giralt
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(11):1878-87.
2010: Matt Kalaycio; Manisha Kukreja; Ann E Woolfrey; Jeffrey Szer; Jorge Cortes; Richard T Maziarz; Brian J Bolwell; Andreas Buser; Edward Copelan; Robert Peter Gale; Vikas Gupta; Dipnarine Maharaj; David I Marks; Steven Z Pavletic; Mary M Horowitz; Mukta Arora
Allogeneic hematopoietic cell transplant for prolymphocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(4):543-7.
2010: Richard T Maziarz
Transplantation for CML: 2010.
Blood 2010;115(10):1860-1.
2010: Mark R Litzow; Sergey Tarima; Waleska S Pérez; Brian J Bolwell; Mitchell S Cairo; Bruce M Camitta; Corey S Cutler; Marcos de Lima; John F Dipersio; Robert Peter Gale; Armand Keating; Hillard M Lazarus; Selina Luger; David I Marks; Richard T Maziarz; Philip L McCarthy; Marcelo C Pasquini; Gordon L Phillips; J Douglas Rizzo; Jorge Sierra; Martin S Tallman; Daniel J Weisdorf
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Blood 2010;115(9):1850-7.
2010: Fausto R Loberiza; Stephanie J Lee; John P Klein; Anna Hassebroek; Jason G Dehn; Haydar Frangoul; Theresa Hahn; Gregory Hale; Hillard M Lazarus; Charles F LeMaistre; Richard T Maziarz; J Douglas Rizzo; Navneet S Majhail
Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):368-75.
2010: Karen K Ballen; Smriti Shrestha; Kathleen A Sobocinski; Mei-Jie Zhang; Asad Bashey; Brian J Bolwell; Francisco Cervantes; Steven M Devine; Robert Peter Gale; Vikas Gupta; Theresa E Hahn; William J Hogan; Nicolaus Kröger; Mark R Litzow; David I Marks; Richard T Maziarz; Philip L McCarthy; Gary Schiller; Harry C Schouten; Vivek Roy; Peter H Wiernik; Mary M Horowitz; Sergio Giralt; Mukta Arora
Outcome of transplantation for myelofibrosis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):358-67.
2010: Richard T Maziarz; Praseeda Sridharan; Susan Slater; Gabrielle Meyers; Mary Post; Dean D Erdman; Teresa C T Peret; Randy A Taplitz
Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(2):192-8.
2010: Cedar J Fowler; Jennifer Dunlap; Darcy Troyer; Peter Stenzel; Elliot Epner; Richard T Maziarz
Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients.
Advances in hematology 2010;2010():601548.
2010: Hillard M Lazarus; Mei-Jie Zhang; Jeanette Carreras; Brandon Hayes-Lattin; Asli Selmin Ataergin; Jacob D Bitran; Brian J Bolwell; Cesar O Freytes; Robert Peter Gale; Steven C Goldstein; gregory alan hale; David J Inwards; Thomas R Klumpp; David I Marks; Richard T Maziarz; Philip L McCarthy; Santiago Pavlovsky; J Douglas Rizzo; Thomas C Shea; Harry C Schouten; Shimon Slavin; Jane N Winter; Koen van Besien; Julie M Vose; Parameswaran N Hari
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):35-45.
2010: H D Adkisson; C Milliman; X Zhang; K Mauch; Richard T Maziarz; Philip R Streeter
Immune evasion by neocartilage-derived chondrocytes: Implications for biologic repair of joint articular cartilage.
Stem cell research 2010;4(1):57-68.
2010: M J Dugan; Richard T Maziarz; W I Bensinger; A Nademanee; J Liesveld; K Badel; C Dehner; C Gibney; G Bridger; G Calandra
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.
Bone marrow transplantation 2010;45(1):39-47.
2009: Ivana N M Micallef; Patrick J Stiff; John F DiPersio; Richard T Maziarz; John M McCarty; Gary Bridger; Gary Calandra
Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1578-86.
2009: K Scott Baker; Stella M Davies; Navneet S Majhail; Anna Hassebroek; John P Klein; Karen K Ballen; Carolyn L Bigelow; Haydar Frangoul; Cheryl L Hardy; Christopher Bredeson; Jason Dehn; Debra Friedman; Theresa Hahn; Gregory Hale; Hillard M Lazarus; Charles F LeMaistre; Fausto Loberiza; Dipnarine Maharaj; Philip McCarthy; Michelle Setterholm; Stephen Spellman; Michael Trigg; Richard T Maziarz; Galen Switzer; Stephanie J Lee; J Douglas Rizzo
Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1543-54.
2009: James L Gajewski; C Frederick LeMaistre; Samuel Michael Silver; Michael C Lill; George B Selby; Mary M Horowitz; J Douglas Rizzo; Helen E Heslop; Claudio Anasetti; Richard T Maziarz
Impending challenges in the hematopoietic stem cell transplantation physician workforce.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1493-501.
2009: John F DiPersio; Ivana N M Micallef; Patrick J Stiff; Brian J Bolwell; Richard T Maziarz; Eric Jacobsen; Auayporn Nademanee; John McCarty; Gary Bridger; Gary Calandra
Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4767-73.
2009: John F DiPersio; Edward A Stadtmauer; Auayporn Nademanee; Ivana N M Micallef; Patrick J Stiff; Jonathan L Kaufman; Richard T Maziarz; Chitra Hosing; Stefan Früehauf; Mitchell Horwitz; Dennis Cooper; Gary Bridger; Gary Calandra
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
Blood 2009;113(23):5720-6.
2009: C J Fowler; A Dunn; Brandon Hayes-Lattin; K Hansen; L Hansen; K Lanier; V Nelson; Tibor J Kovacsovics; J Leis; G Calandra; Richard T Maziarz
Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience.
Bone marrow transplantation 2009;43(12):909-17.
2009: Paul J Martin; Barry E Storer; Scott D Rowley; Mary E D Flowers; Stephanie J Lee; Paul A Carpenter; John R Wingard; Paul J Shaughnessy; Marcel P Devetten; Madan Jagasia; Joseph W Fay; Koen van Besien; Vikas Gupta; Carrie L Kitko; Laura J Johnston; Richard T Maziarz; Mukta Arora; Pamala A Jacobson; Daniel Weisdorf
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Blood 2009;113(21):5074-82.
2009: Marcello Rotta; Barry E Storer; Firoozeh Sahebi; Judith A Shizuru; Benedetto Bruno; Thoralf Lange; Edward D Agura; Peter A McSweeney; Michael Allen Pulsipher; Parameswaran Hari; Richard T Maziarz; Thomas R Chauncey; Frederick R Appelbaum; Mohamed L Sorror; William I Bensinger; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
2009: Joseph S Bubalo; Myrna Y Munar; Ganesh Cherala; Brandon Hayes-Lattin; Richard T Maziarz
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever.
Antimicrobial agents and chemotherapy 2009;53(2):428-34.
2009: Jeffrey W Tyner; Marc Loriaux; H Erickson; C A Eide; J Deininger; Mary MacPartlin; S G Willis; Thoralf Lange; Brian J Druker; Tibor J Kovacsovics; Richard T Maziarz; N Gattermann; Michael W N Deininger
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia.
Leukemia 2009;23(2):406-9.
2009: Hong-Yan Du; Elena Pumbo; Jennifer Ivanovich; Ping An; Richard T Maziarz; Ulrike M Reiss; Deborah Chirnomas; Akiko Shimamura; Adrianna Vlachos; Jeffrey Lipton; Rakesh K Goyal; Frederick D Goldman; David B Wilson; Philip J Mason; Monica Bessler
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
Blood 2009;113(2):309-16.
2009: Marcel P Devetten; Parameswaran N Hari; Jeanette Carreras; Brent R Logan; Koen van Besien; Christopher N Bredeson; Cesar O Freytes; Robert Peter Gale; John Gibson; Sergio Giralt; Steven C Goldstein; Vikas Gupta; David I Marks; Richard T Maziarz; Julie M Vose; Hillard M Lazarus; Paolo Anderlini
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):109-17.
2009: Magdalena Kovacsovics-Bankowski; Philip R Streeter; Kelsey A Mauch; Mark R Frey; Amy Raber; Wouter van't Hof; Robert Deans; Richard T Maziarz
Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease.
Cellular immunology 2009;255(1-2):55-60.
2008: Theresa Hahn; Philip L McCarthy; Mei-Jie Zhang; Dan Wang; Mukta Arora; Haydar Frangoul; Robert Peter Gale; gregory alan hale; John Horan; Luis Isola; Richard T Maziarz; Jon van Rood; Vikas Gupta; Joerg Halter; Vijay Reddy; Pierre Tiberghien; Mark Litzow; Claudio Anasetti; Stephen Pavletic; Olle Ringdén
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5728-34.
2008: Lauri M Burroughs; Paul V O'Donnell; Brenda M Sandmaier; Barry E Storer; Leo Luznik; HEATHER SYMONS; Richard J Jones; Richard F Ambinder; Michael B Maris; Karl G Blume; Dietger Niederwieser; Benedetto Bruno; Richard T Maziarz; Michael Allen Pulsipher; Finn B Petersen; Rainer Storb; Ephraim J Fuchs; David G Maloney
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1279-87.
2008: Andrew R Rezvani; Lalitha Norasetthada; Ted Gooley; Mohamed Sorror; Michelle E Bouvier; Firoozeh Sahebi; Edward Agura; Thomas R Chauncey; Richard T Maziarz; Michael Maris; Judith Shizuru; Benedetto Bruno; Christopher Bredeson; Thoralf Lange; Andrew Yeager; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
British journal of haematology 2008;143(3):395-403.
2008: Mohamed L Sorror; Barry E Storer; Brenda M Sandmaier; Michael B Maris; Judith A Shizuru; Richard T Maziarz; Edward Agura; Thomas R Chauncey; Michael Allen Pulsipher; Peter A McSweeney; James C Wade; Benedetto Bruno; Amelia A Langston; Jerald P Radich; Dietger Niederwieser; Karl G Blume; Rainer Storb; David G Maloney
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4912-20.
2008: Stephanie J Lee; Manisha Kukreja; Tao Wang; Sergio Giralt; Jeffrey Szer; Mukta Arora; Ann E Woolfrey; Francisco Cervantes; Richard E Champlin; Robert Peter Gale; Joerg Halter; Armand Keating; David I Marks; Philip L McCarthy; Eduardo Olavarria; Edward A Stadtmauer; Manuel Abecasis; Vikas Gupta; H Jean Khoury; Biju George; gregory alan hale; Jane L Liesveld; David A Rizzieri; Joseph H Antin; Brian J Bolwell; Matthew H Carabasi; Edward Copelan; Osman Ilhan; Mark R Litzow; Harold C Schouten; Axel R Zander; Mary M Horowitz; Richard T Maziarz
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
Blood 2008;112(8):3500-7.
2008: Sonali M Smith; Koen van Besien; Jeanette Carreras; Asad Bashey; Mitchell S Cairo; Cesar O Freytes; Robert Peter Gale; gregory alan hale; Brandon Hayes-Lattin; Leona A Holmberg; Armand Keating; Richard T Maziarz; Philip L McCarthy; Willis H Navarro; Santiago Pavlovsky; Harry C Schouten; Matthew Seftel; Peter H Wiernik; Julie M Vose; Hillard M Lazarus; Parameswaran Hari
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):904-12.
2008: David I Marks; Waleska S Pérez; Wensheng He; Mei-Jie Zhang; Michael Bishop; Brian J Bolwell; Christopher N Bredeson; Edward A Copelan; Robert Peter Gale; Vikas Gupta; gregory alan hale; Luis M Isola; Ann Jakubowski; Armand Keating; Thomas R Klumpp; Hillard M Lazarus; Jane L Liesveld; Richard T Maziarz; Philip L McCarthy; Mitchell Sabloff; Gary Schiller; Jorge Sierra; Martin S Tallman; Edmond WALLER; Peter H Wiernik; Daniel J Weisdorf
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
Blood 2008;112(2):426-34.
2008: Mohamed Sorror; Barry Storer; Brenda M Sandmaier; David G Maloney; Thomas R Chauncey; Amelia Langston; Richard T Maziarz; Michael Allen Pulsipher; Peter A McSweeney; Rainer Storb
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer 2008;112(9):1992-2001.
2008: Richard T Maziarz
Who with chronic myelogenous leukemia to transplant in the era of tyrosine kinase inhibitors?
Current opinion in hematology 2008;15(2):127-33.
2008: Richard F Schlenk; Marcelo C Pasquini; Waleska S Pérez; Mei-Jie Zhang; Jürgen Krauter; Joseph H Antin; Asad Bashey; Brian J Bolwell; Thomas Büchner; Jean-Yves Cahn; Mitchell S Cairo; Edward A Copelan; Corey Cutler; Hartmut Döhner; Robert Peter Gale; Osman Ilhan; Hillard M Lazarus; Jane L Liesveld; Mark R Litzow; David I Marks; Richard T Maziarz; Philip L McCarthy; Stephen D Nimer; Jorge Sierra; Martin S Tallman; Daniel J Weisdorf; Mary M Horowitz; Arnold Ganser
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):187-96.
2008: Andrew R Rezvani; Barry Storer; Michael B Maris; Mohamed L Sorror; Edward Agura; Richard T Maziarz; James C Wade; Thomas R Chauncey; Stephen J Forman; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Brenda M Sandmaier; Rainer Storb; David G Maloney
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):211-7.
2008: M Kovacsovics-Bankowski; K Mauch; A Raber; Philip R Streeter; R J Deans; Richard T Maziarz; W Van't Hof
Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells.
Cytotherapy 2008;10(7):730-42.
2007: Frédéric Baron; Brenda M Sandmaier; Barry E Storer; Michael B Maris; Amelia A Langston; Thoralf Lange; Effie W Petersdorf; Wolfgang A Bethge; Richard T Maziarz; Peter A McSweeney; Michael Allen Pulsipher; James C Wade; Thomas R Chauncey; Judith A Shizuru; Mohamed L Sorror; Ann Woolfrey; David G Maloney; Rainer Storb
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
2007: Sergio Giralt; Mukta Arora; John M Goldman; Stephanie J Lee; Richard T Maziarz; Philip L McCarthy; Kathleen A Sobocinski; Mary M Horowitz
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.
British journal of haematology 2007;137(5):461-7.
2007: Yanping Zhong; Antony C (Tony) Bakke; Guang Fan; Rita M Braziel; Ken M Gatter; Jose F Leis; Richard T Maziarz; James Z Huang
Drug resistance in B-cell chronic lymphocytic leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay.
Cytometry. Part B, Clinical cytometry 2007;72(3):189-95.
2006: Tibor J Kovacsovics; Richard T Maziarz
Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantation.
Current oncology reports 2006;8(5):343-51.
2006: Frédéric Baron; Rainer Storb; Barry E Storer; Michael B Maris; Dietger Niederwieser; Judith A Shizuru; Thomas R Chauncey; Benedetto Bruno; Stephen J Forman; Peter A McSweeney; Richard T Maziarz; Michael Allen Pulsipher; Edward D Agura; James Wade; Mohamed L Sorror; David G Maloney; Brenda M Sandmaier
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
2006: Michael W N Deininger; Michael Schleuning; Hilde Greinix; Herbert G Sayer; Thomas Fischer; Jesus Martinez; Richard T Maziarz; Eduardo Olavarria; Leo Verdonck; Kerstin Schaefer; Conxa Boqué; Edgar Faber; Arnon Nagler; Enrico Pogliani; Nigel Russell; Liisa Volin; Urs Schanz; Gottfried Doelken; Michael Kiehl; Axel A Fauser; Brian J Druker; Anna Sureda; Simona Iacobelli; Ronald Brand; Rainer Krahl; Thoralf Lange; Andreas Hochhaus; Alois Gratwohl; Hans Kolb; Dietger Niederwieser
The effect of prior exposure to imatinib on transplant-related mortality.
Haematologica 2006;91(4):452-9.
2006: Michael B Maris; Brenda M Sandmaier; Barry E Storer; David G Maloney; Judith A Shizuru; Edward Agura; Constanze Kliem; Michael Allen Pulsipher; Richard T Maziarz; Peter A McSweeney; James Wade; Amelia A Langston; Thomas R Chauncey; Benedetto Bruno; Karl G Blume; Rainer Storb
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):454-65.
2006: Michael J Mauro; Richard T Maziarz
Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used?
Mayo Clinic proceedings. Mayo Clinic 2006;81(3):404-16.
2006: Martin S Tallman; Waleska S Pérez; Hillard M Lazarus; Robert Peter Gale; Richard T Maziarz; Jacob M Rowe; David I Marks; Jean-Yves Cahn; Asad Bashey; Michael Bishop; Neal Christiansen; Stanley R Frankel; Juan J García; Osman Ilhan; Mary J Laughlin; Jane Liesveld; Charles Linker; Mark R Litzow; Selina Luger; Philip L McCarthy; Gustavo A Milone; Santiago Pavlovsky; Gordon L Phillips; James A Russell; Ruben A Saez; Gary Schiller; Jorge Sierra; Roy S Weiner; Axel R Zander; Mei-Jie Zhang; Armand Keating; Daniel J Weisdorf; Mary M Horowitz
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):204-16.
2006: Ute Hegenbart; Dietger Niederwieser; Brenda M Sandmaier; Michael B Maris; Judith A Shizuru; Hildegard Greinix; Catherine Cordonnier; Bernard Rio; Alois Gratwohl; Thoralf Lange; Haifa-Kathrin Al-Ali; Barry Storer; David Maloney; Peter McSweeney; Thomas R Chauncey; Edward Agura; Benedetto Bruno; Richard T Maziarz; Finn Petersen; Rainer Storb
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):444-53.
2006: Deborah H Eldredge; Lillian M Nail; Richard T Maziarz; Lisa K Hansen; Danita Lee Ewing; Patricia G Archbold
Explaining family caregiver role strain following autologous blood and marrow transplantation.
Journal of psychosocial oncology 2006;24(3):53-74.
2005: Brandon Hayes-Lattin; J F Leis; Richard T Maziarz
Isolation in the allogeneic transplant environment: how protective is it?
Bone marrow transplantation 2005;36(5):373-81.
2005: Hillard M Lazarus; Omer N Koc; Steven M Devine; Peter Curtin; Richard T Maziarz; H Kent Holland; Elizabeth J Shpall; Philip McCarthy; Kerry Atkinson; Brenda W Cooper; Stanton L Gerson; Mary J Laughlin; Fausto R Loberiza; Annemarie Moseley; Andrea Bacigalupo
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):389-98.
2005: Mark Bonyhadi; Mark Frohlich; Angela Rasmussen; Christophe Ferrand; Laura Grosmaire; Eric Robinet; Jose F Leis; Richard T Maziarz; Pierre Tiberghien; Ronald J Berenson
In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(4):2366-75.
2004: Michael B Maris; Brenda M Sandmaier; Barry E Storer; Thomas R Chauncey; Monic J Stuart; Richard T Maziarz; Edward Agura; Amelia A Langston; Michael Allen Pulsipher; Rainer Storb; David G Maloney
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Blood 2004;104(12):3535-42.
2004: Jose F Leis; Steven L Primack; Susan E Schubach; Peter T Curtin; Brian J Druker; Richard T Maziarz
Management of life-threatening pulmonary leukostasis with single agent imatinib mesylate during CML myeloid blast crisis.
Haematologica 2004;89(9):ECR30.
2004: Stephanie J Lee; David Zahrieh; Edward Agura; Margaret L MacMillan; Richard T Maziarz; Philip L McCarthy; Vincent T Ho; Corey Cutler; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.
Blood 2004;104(5):1559-64.
2004: Francis Giles; Roberto Rodriguez; Daniel Weisdorf; John R Wingard; Paul J Martin; Thomas R Fleming; Stuart L Goldberg; Elias J Anaissie; Brian J Bolwell; Nelson J Chao; Thomas C Shea; Mark M Brunvand; William Vaughan; Finn Petersen; Mark Schubert; Hillard M Lazarus; Richard T Maziarz; Margarida Silverman; Roy A Beveridge; Rebecca Redman; Janis G Pulliam; Patricia Devitt-Risse; Henry J Fuchs; David D Hurd
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
Leukemia research 2004;28(6):559-65.
2004: L N Walker; Ken M Gatter; Harmanjatinder S Sekhon; Richard T Maziarz
Late relapse of myelodysplasia after allogeneic transplantation concomitant with new presentation of invasive liposarcoma as a secondary neoplasm.
Bone marrow transplantation 2004;33(12):1215-8.
2004: Philip R Streeter; Xingqi Zhang; Thomas V Tittle; Catherine N Schön; Andrew D Weinberg; Richard T Maziarz
CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):298-309.
2004: Michael J Mauro; Brian J Druker; Richard T Maziarz
Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remission.
Leukemia research 2004;28 Suppl 1():S71-3.
2004: Jose F Leis; Daniel E Stepan; Peter T Curtin; John M Ford; Bin Peng; Susan E Schubach; Brian J Druker; Richard T Maziarz
Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571).
Leukemia & lymphoma 2004;45(4):695-8.
2004: Brandon Hayes-Lattin; Richard T Maziarz
Update in the epidemiology, prophylaxis, and treatment of fungal infections in patients with hematologic disorders.
Leukemia & lymphoma 2004;45(4):669-80.
2004: Brandon Hayes-Lattin; Timothy J Seipel; Ken M Gatter; Michael C Heinrich; Richard T Maziarz
Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation.
American journal of hematology 2004;75(3):142-5.
2003: Koen van Besien; Fausto R Loberiza; Ruta Bajorunaite; James O Armitage; Asad Bashey; Linda J Burns; Cesar O Freytes; John Gibson; Mary M Horowitz; David J Inwards; David I Marks; Rodrigo Martino; Richard T Maziarz; Arturo Molina; Santiago Pavlovsky; Andrew L Pecora; Harry C Schouten; Thomas C Shea; Hillard M Lazarus; J Douglas Rizzo; Julie M Vose
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.
Blood 2003;102(10):3521-9.
2003: Richard T Maziarz; Michael J Mauro
Transplantation for chronic myelogenous leukemia: yes, no, maybe so. . . An Oregon perspective.
Bone marrow transplantation 2003;32(5):459-69.
2003: Richard T Maziarz; Ruben A Mesa; Ayalew Tefferi
Allogeneic stem cell transplantation for chronic myeloproliferative disorders and myelodysplastic syndromes: the question is "when?".
Mayo Clinic proceedings. Mayo Clinic 2003;78(8):941-3.
2003: F Gutierrez-Delgado; Leona A Holmberg; Heather A Hooper; Stephen H Petersdorf; Oliver W Press; Richard T Maziarz; David Maloney; Thomas R Chauncey; Frederick R Appelbaum; William I Bensinger
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen.
Bone marrow transplantation 2003;32(3):279-85.
2003: Drew J Winston; Richard T Maziarz; Pranatharthi H Chandrasekar; Hillard M Lazarus; Mitchell Goldman; Jeffrey L Blumer; Gerhard J Leitz; Mary Territo
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Annals of internal medicine 2003;138(9):705-13.
2003: Andrew D Jones; Richard T Maziarz; Jason Gilster; John S Domreis; Clifford W Deveney; Brett C Sheppard
Surgical complications of bone marrow transplantation.
American journal of surgery 2003;185(5):481-4.
2003: John E Levine; Richard E Harris; Fausto R Loberiza; James O Armitage; Julie M Vose; Koen van Besien; Hillard M Lazarus; Mary M Horowitz; Asad Bashey; Brian J Bolwell; Linda J Burns; Mitchell S Cairo; Richard E Champlin; Cesar O Freytes; John Gibson; Steve C Goldstein; Mary J Laughlin; John Lister; David I Marks; Richard T Maziarz; Alan Marshall Miller; Gustavo A Milone; Santiago Pavlovsky; Andrew L Pecora; J Douglas Rizzo; Gary Schiller; Harry C Schouten; Mei-Jie Zhang
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
Blood 2003;101(7):2476-82.
2003: Michael O'Dwyer; Ken M Gatter; Marc Loriaux; Brian J Druker; Susan B Olson; R Ellen Magenis; Helen Lawce; Michael J Mauro; Richard T Maziarz; Rita M Braziel
Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
Leukemia 2003;17(3):481-7.
2002: Brandon Hayes-Lattin; Peter T Curtin; William H Fleming; J F Leis; D E Stepan; Susan E Schubach; Richard T Maziarz
Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis.
Bone marrow transplantation 2002;30(5):279-85.
2001: David J Araten; D Swirsky; Anastasios Karadimitris; Rosario Notaro; Khedoudja Nafa; Monica Bessler; Howard T Thaler; Hugo Castro-Malaspina; Barrett H Childs; Farid Boulad; M Weiss; N Anagnostopoulos; Abdullah Kutlar; D G Savage; Richard T Maziarz; Suresh C Jhanwar; Lucio Luzzatto
Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria.
British journal of haematology 2001;115(2):360-8.
2001: F Gutierrez-Delgado; David G Maloney; Oliver W Press; J Golden; Leona A Holmberg; Richard T Maziarz; Heather A Hooper; C Dean Buckner; Frederick R Appelbaum; William I Bensinger
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.
Bone marrow transplantation 2001;28(5):455-61.
2001: Brandon Hayes-Lattin; Richard T Maziarz; Tomasz M Beer
Allogeneic stem-cell transplantation in renal-cell carcinoma.
Current oncology reports 2001;3(5):433-7.
2001: Joseph S Bubalo; F Seelig; S Karbowicz; Richard T Maziarz
Randomized open-label trial of dolasetron for the control of nausea and vomiting associated with high-dose chemotherapy with hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(8):439-45.
2000: F Gutierrez-Delgado; Leona A Holmberg; Heather A Hooper; Frederick R Appelbaum; R B Livingston; Richard T Maziarz; P Weiden; Saul E Rivkin; P Montgomery; K Kawahara; William I Bensinger
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.
Bone marrow transplantation 2000;26(1):51-9.
2000: Saul Yanovich; Peggie Mitsky; Kenneth Cornetta; Richard T Maziarz; C Rosenfeld; D S Krause; Jean-Pierre Lotz; J D Bitran; S Williams; R Preti; G Somlo; B Burtness; B Mills
Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
Bone marrow transplantation 2000;25(11):1165-74.
2000: Alan F List; Richard T Maziarz; Patrick J Stiff; J Jansen; J Liesveld; F Andrews; M Schuster; Steven Neil Wolff; M Litzow; Chatchada Karanes; Seth Dahlberg; B Kirkhart; J A Bianco; jack w singer
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
Bone marrow transplantation 2000;25(3):283-91.
1999: Leona A Holmberg; Michael Boeckh; Heather A Hooper; Wendy Leisenring; Scott D Rowley; Shelly Heimfeld; Oliver W Press; David G Maloney; Peter McSweeney; Lawrence Corey; Richard T Maziarz; Frederick R Appelbaum; William I Bensinger
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.
Blood 1999;94(12):4029-35.
1999: Craig Nichols; Richard T Maziarz
High dose chemotherapy--results of American studies.
International journal of cancer. Journal international du cancer 1999;83(6):841-3.
1999: D J Nichols; Richard T Maziarz; M T Haupt
Mechanical ventilation in hematopoietic stem cell transplant patients: is there need for reevaluation?
Chest 1999;116(4):857-9.
1999: Douglas Adkins; Robert Brown; Kathryn Trinkaus; Richard T Maziarz; S Luedke; Cesar O Freytes; B Needles; D Wienski; P Fracasso; T Pluard; W Moriconi; T Ryan; K Hoelzer; S Safdar; T Rearden; G Rodriguez; Hanna Khoury; Ravi Vij; John DiPersio
Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2006-14.
1998: H Guo; Thomas V Tittle; H Allen; Richard T Maziarz
Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2.
Experimental cell research 1998;245(1):57-68.
1998: Leona A Holmberg; Taner Demirer; Scott D Rowley; C Dean Buckner; G Goodman; Richard T Maziarz; JP Klarnet; N Zuckerman; G Harrer; R McCloskey; R Gersh; R Goldberg; W Nichols; A Jacobs; P Weiden; P Montgomery; Saul E Rivkin; Frederick R Appelbaum; William I Bensinger
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
Bone marrow transplantation 1998;22(7):651-9.
1997: K Schiffman; C Dean Buckner; Richard T Maziarz; David G Maloney; Frederick R Appelbaum; Oliver W Press; Ted Gooley; Leona A Holmberg; Kathy Lilleby; Reginald Clift; N Zuckerman; JP Klarnet; C Weaver; Thomas R Chauncey; William I Bensinger
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):261-6.
1997: R Keaney Rathbun; Gregory R Faulkner; M H Ostroski; Tracy A Christianson; G Hughes; G Jones; R Cahn; Richard T Maziarz; G Royle; Winifred Keeble; Michael C Heinrich; Markus Grompe; PA Tower; Grover C Bagby
Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.
Blood 1997;90(3):974-85.
1997: Thomas V Tittle; A D Weinberg; C N Steinkeler; Richard T Maziarz
Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease.
Blood 1997;89(12):4652-8.
1997: William I Bensinger; K S Schiffman; Leona A Holmberg; Frederick R Appelbaum; Richard T Maziarz; P Montgomery; E Ellis; Saul E Rivkin; P Weiden; Kathy Lilleby; Scott D Rowley; Stephen H Petersdorf; JP Klarnet; W Nichols; A Hertler; R McCroskey; Charles H Weaver; C Dean Buckner
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.
Bone marrow transplantation 1997;19(12):1183-9.
1997: Masataka Kasai; T Matsuzaki; K Katayanagi; A Omori; Richard T Maziarz; Jack L Strominger; Katsunori Aoki; K Suzuki
The translin ring specifically recognizes DNA ends at recombination hot spots in the human genome.
The Journal of biological chemistry 1997;272(17):11402-7.
1996: M W Brunvand; William I Bensinger; E Soll; Charles H Weaver; Scott D Rowley; Frederick R Appelbaum; Kathy Lilleby; Reginald Clift; T A Gooley; Oliver W Press; Alexander Fefer; Rainer Storb; Jean E Sanders; P L Martin; Thomas R Chauncey; Richard T Maziarz; N Zuckerman; P Montgomery; R Dorn; P L Weiden; Taner Demirer; Leona A Holmberg; K Schiffman; P A McSweeney; C Dean Buckner
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1996;18(1):131-41.
1996: K S Schiffman; William I Bensinger; Frederick R Appelbaum; Scott D Rowley; Kathy Lilleby; Reginald Clift; Charles H Weaver; Taner Demirer; Jean E Sanders; S Petersdorf; T Gooley; P Weiden; N Zuckerman; P Montgomery; Richard T Maziarz; J P Klarnet; Saul E Rivkin; K Trueblood; Rainer Storb; Leona A Holmberg; C Dean Buckner
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
Bone marrow transplantation 1996;17(6):943-50.
1996: William I Bensinger; Scott D Rowley; Taner Demirer; Kathy Lilleby; K Schiffman; Reginald Clift; Frederick R Appelbaum; Alexander Fefer; T Barnett; Rainer Storb; Thomas R Chauncey; Richard T Maziarz; J Klarnet; P McSweeney; Leona A Holmberg; David G Maloney; Charles H Weaver; C Dean Buckner
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
1996: PJ Valentine; K Meyer; M M Rivera; C Lipps; C. David Pauza; Richard T Maziarz; Magdalene So; Fred Heffron
Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant.
Vaccine 1996;14(2):138-46.
1996: A D Weinberg; Dennis N Bourdette; T J Sullivan; M Lemon; J J Wallin; Richard T Maziarz; Michael P Davey; F Palida; W Godfrey; E Engleman; R J Fulton; Halina Offner; Arthur Vandenbark
Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis.
Nature medicine 1996;2(2):183-9.
1995: L L Fields; Clifton R White; Richard T Maziarz
Rapid development of disseminated superficial porokeratosis after transplant induction therapy.
Bone marrow transplantation 1995;15(6):993-5.
1994: M P Braun; Richard T Maziarz
Abscopal depression of G-CSF mobilized peripheral stem cells.
Bone marrow transplantation 1994;14(6):1005-7.
1994: Masataka Kasai; Katsunori Aoki; Y Matsuo; J Minowada; Richard T Maziarz; Jack L Strominger
Recombination hotspot associated factors specifically recognize novel target sequences at the site of interchromosomal rearrangements in T-ALL patients with t(8;14)(q24;q11) and t(1;14)(p32;q11).
International immunology 1994;6(7):1017-25.
1994: K Aoki; K Nakahara; C Ikegawa; M Seto; T Takahashi; J Minowada; Jack L Strominger; Richard T Maziarz; M Kasai
Nuclear proteins binding to a novel target sequence within the recombination hotspot regions of Bcl-2 and the immunoglobulin DH gene family.
Oncogene 1994;9(4):1109-15.
1994: I Yoshino; G E Peoples; Peter S Goedegebuure; Richard T Maziarz; Timothy J Eberlein
Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(5):2393-400.
1993: D J Araten; T Lawton; James L M Ferrara; Joseph H Antin; E Milford; Charles B Carpenter; Richard T Maziarz
In vitro alloreactivity against host antigens in an adult HLA-mismatched bone marrow transplant recipient despite in vivo host tolerance.
Transplantation 1993;55(1):76-82.
1992: Masataka Kasai; Richard T Maziarz; Katsunori Aoki; E Macintyre; Jack L Strominger
Molecular involvement of the pvt-1 locus in a gamma/delta T-cell leukemia bearing a variant t(8;14)(q24;q11) translocation.
Molecular and cellular biology 1992;12(10):4751-7.
1992: Richard T Maziarz; Robert J Arceci; S C Bernstein; Lindsay Frazier; Brian R Smith; M Kasai; R Tantravahi; Jack L Strominger
A gamma delta+ T-cell leukemia bearing a novel t(8;14)(q24;q11) translocation demonstrates spontaneous in vitro natural killer-like activity.
Blood 1992;79(6):1523-31.
1992: C B Treseler; Richard T Maziarz; Stuart M Levitz
Biological activity of interleukin-2 bound to Candida albicans.
Infection and immunity 1992;60(1):183-8.
1991: Stuart M Levitz; T P Farrell; Richard T Maziarz
Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture.
The Journal of infectious diseases 1991;163(5):1108-13.
1991: Richard T Maziarz; Veronika Groh; M Prendergast; M Fabbi; Jack L Strominger; Steven J Burakoff
Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing.
International journal of cancer. Journal international du cancer 1991;48(1):142-7.
1990: H Allen; J Hsuan; S Clark; Richard T Maziarz; M D Waterfield; R A Flavell; J Haley
Expression of epidermal-growth-factor receptor in the K562 cell line by transfection. Altered receptor biochemistry.
The Biochemical journal 1990;271(3):785-90.
1990: Richard T Maziarz; S J Mentzer; Steven J Burakoff; Douglas V Faller
Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis.
Cellular immunology 1990;130(2):329-38.
1990: Richard T Maziarz; Steven J Burakoff; Douglas V Faller
The regulation of exogenous and endogenous class I MHC genes in a human tumor cell line, K562.
Molecular immunology 1990;27(2):135-42.
1989: B E Tomkinson; Richard T Maziarz; John L Sullivan
Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(2):660-70.
1989: Veronika Groh; M Fabbi; F Hochstenbach; Richard T Maziarz; Jack L Strominger
Double-negative (CD4-CD8-) lymphocytes bearing T-cell receptor alpha and beta chains in normal human skin.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(13):5059-63.
1989: Jack L Strominger; M Fabbi; M Prendergast; Richard T Maziarz; Steven J Burakoff; Veronika Groh
Novel subsets of human T cells (CD4+ CD8- TCR gamma delta and CD4- CD8- TCR alpha beta) and T-cell development.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1989;4():43-7.
1988: B E Bierer; Stephen G Emerson; Joseph H Antin; Richard T Maziarz; J M Rappeport; Brian R Smith; Steven J Burakoff
Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation.
Transplantation 1988;46(6):835-9.
1988: Richard T Maziarz; I Tepler; Joseph H Antin; M A Keroack; Winthrop H Churchill; W Holmes; J Rappeport
Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemia.
Annals of internal medicine 1988;109(4):292-4.
1988: Richard T Maziarz; S J Burakoff; J A Bluestone
The alpha-3 domain of class I MHC proteins influences cytotoxic T lymphocyte recognition of antigenic determinants located within the alpha-1 and alpha-2 domains.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(12):4372-7.
1986: Richard T Maziarz; S J Burakoff; C S Reiss
Viral-restricted cytolytic T lymphocyte recognition of hybrid human-murine class I histocompatibility antigens.
Cellular immunology 1986;99(1):279-86.
1986: Richard T Maziarz; J Fraser; J L Strominger; S J Burakoff
The human HLA-specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the alpha 2 domain of murine H-2Db.
Immunogenetics 1986;24(3):206-8.
1985: Richard T Maziarz; H Allen; J L Strominger; R Flavell; P A Biro; S J Burakoff
Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(18):6276-80.
1985: C Bernabeu; Richard T Maziarz; C Murre; C Terhorst
beta 2-Microglobulin from serum associates with several class I antigens expressed on the surface of mouse L-cells.
Molecular immunology 1985;22(8):955-60.
1984: C Bernabeu; Richard T Maziarz; H Spits; J de Vries; S J Burakoff; C Terhorst
Coexpression of the human HLA-A2 or HLA-B7 heavy chain gene and human beta 2-microglobulin gene in L cells.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(6):3188-94.
1984: V Duprez; Richard T Maziarz; O Weinberger; S J Burakoff
Thymectomized, irradiated, and bone marrow-reconstituted chimeras have normal cytolytic T lymphocyte precursors but a defect in lymphokine production.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(5):2185-9.
1983: C Bernabeu; D Finlay; M van de Rijn; Richard T Maziarz; P A Biro; H Spits; J de Vries; C P Terhorst
Expression of the major histocompatibility antigens HLA-A2 and HLA-B7 by DNA-mediated gene transfer.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(4):2032-7.